Using CCM and DHPLC to detect mutations in the glucocorticoid receptor in atherosclerosis: a comparison
- 1 January 2001
- journal article
- research article
- Published by Elsevier in Journal of Biochemical and Biophysical Methods
- Vol. 47 (1-2) , 91-100
- https://doi.org/10.1016/s0165-022x(00)00155-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Expression of TGF-β Receptors in Human Atherosclerosis: Evidence for Acquired Resistance to Apoptosis due to Receptor ImbalanceJournal of Molecular and Cellular Cardiology, 1999
- Apoptosis in Restenosis Versus Stable-Angina AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.Journal of Clinical Investigation, 1997
- Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.Journal of Clinical Investigation, 1995
- Pharmacological Approaches to the Prevention of Restenosis Following AngioplastyDrugs, 1993
- A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.Circulation, 1990
- Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomyAtherosclerosis, 1989
- Effects of glucocorticoids on Na+/H+ exchange and growth in cultured vascular smooth muscle cellsJournal of Cellular Physiology, 1988
- Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1985
- Glucocorticoid influence on growth of vascular wall cells in cultureJournal of Cellular Physiology, 1982